The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic syndrome.

The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic syndrome in shabestar.

Inclusion Criteria:

• presence of ≥3 of the following diagnostic of MetS:

  • serum TGs of at least 150 mg/dL,
  • waist circumference of more than 102 cm (40 in) in men and more than 88 cm (35 in) in women,
  • high-density lipoprotein (HDL) level less than 40 mg/dL in men and less than 50 mg/dL in women,
  • blood pressure 135/85 mm Hg or higher, or
  • fasting glucose 100 mg/dL or Higher

Exclusion Criteria:

• liver cirrhosis,
• chronic pancreatitis,
• gastrointestinal or connective diseases,
• kidney stones, or
• renal failure,
• alcohol Consumption,
• having an allergy to pomegranate juice,
• a change in diet,
• the large increase in LDL so that required drug treatment.
• use of statins of fibrates, corticosteroids, nitrates, acetyl-salicylic acid or other anti-platelet drugs, oral hypoglycemic drugs, nonsteroidal anti-inflammatory drugs, or drugs interfering with coagulation;
• pregnancy or lactation in the past 6 mo, supplementation with vitamins or antioxidants